1. Home
  2. VERA vs DEI Comparison

VERA vs DEI Comparison

Compare VERA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$49.71

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$11.59

Market Cap

2.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
DEI
Founded
2016
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.6B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
VERA
DEI
Price
$49.71
$11.59
Analyst Decision
Strong Buy
Hold
Analyst Count
10
8
Target Price
$67.67
$15.29
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
6.53%
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
N/A
$1,000,336,000.00
Revenue This Year
N/A
$2.82
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$93.47
Revenue Growth
N/A
3.61
52 Week Low
$18.53
$11.43
52 Week High
$50.16
$20.50

Technical Indicators

Market Signals
Indicator
VERA
DEI
Relative Strength Index (RSI) 83.43 36.68
Support Level $40.38 $11.68
Resistance Level $47.10 $12.16
Average True Range (ATR) 3.35 0.29
MACD 1.34 0.04
Stochastic Oscillator 99.33 4.27

Price Performance

Historical Comparison
VERA
DEI

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

Share on Social Networks: